Israel’s Theranica (reported here previously) has received US FDA clearance to market its Nerivio therapeutic device for the acute treatment of episodic or chronic migraine in people 12 years and older. Theranica’s migraine patch was approved by the FDA in 2019.
https://nocamels.com/2021/01/israeli-device-gets-fda-approval-for-migraine-treatment-in-adolescents/